Skip To Content
Click for DHHS Home Page
Click for the SAMHSA Home Page
 Click for the OAS Drug Abuse Statistics Home Page
Click for What's New
Click for Recent Reports and HighlightsClick for Information by Topic Click for OAS Data Systems and more Pubs Click for Data on Specific Drugs of Use Click for Short Reports and Facts Click for Frequently Asked Questions Click for Publications Click to send OAS Comments, Questions and Requests Click for OAS Home Page Click for Substance Abuse and Mental Health Services Administration Home Page Click to Search Our Site

Characteristics of Primary Tranquilizer Treatment Admissions: 2002

The DASIS Report: Characteristics of Primary Tranquilizer Admissions, 2002

Highlights:

  • Tranquilizers are a class of central nervous depressant drugs commonly prescribed for anxiety or insomnia. Tranquilizers include benzodiazepines, such as Valium®, Xanax®, and Librium®, as well as non-benzodiazepine tranquilizers.

  • Between 1992 and 2002, substance abuse treatment admissions reporting tranquilizers as their primary substance of abuse to SAMHSA's Treatment Episode Data Set (TEDS) increased 79% from 4,600 admissions in 1992 to 8,300 in 2002.

  • Among the additional 32,800 admissions which reported tranquilizers as a secondary or tertiary substance of abuse in 2002, opiates (46%) and alcohol (30%) were the most common primary substances of abuse.

  • Primary tranquilizer admissions were most frequent in the South (40%) and least frequent in the West (12%) and Midwest (15%).

Other Data on Specific Drugs

Reports on Substance Abuse Treatment

Other Topics

Other OAS Publications and Services

This Short Report, The DASIS Report: Characteristics of Primary Tranquilizer Admissions, 2002 , is based on the Drug and Alcohol Services Information System (DASIS), the primary source of national data on substance abuse treatment.  DASIS is conducted by the Office of Applied Studies (OAS) in the Substance Abuse and Mental Health Services Administration (SAMHSA).  

This is the page footer.

This page has been accessed 76169 times since 7/21/05.

This page was last updated on July 27, 2006.

SAMHSA, an agency in the Department of Health and Human Services, is the Federal Government's lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States.

This is a line.

   Site Map | Contact Us | Accessibility | Privacy Policy | Freedom of Information Act
 Disclaimer | Department of Health and Human Services | SAMHSA | White House | USA.gov

* PDF formatted files require that Adobe Acrobat Reader® program is installed on your computer. Click here to download this FREE software now from Adobe.